Clinical Trial Update: MRI Gadopiclenol Enhanced Imaging of CNS Tumors

View source ↗

Summary

ClinicalTrials.gov entry indicates the study evaluating gadopiclenol-enhanced MRI for central nervous system tumor imaging has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Neoplasms

Drugs mentioned

• gadopiclenol (gadopiclenol)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Image | Status: WITHDRAWN